Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis
- PMID: 17376024
- DOI: 10.1517/14656566.8.5.701
Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis
Abstract
Azelastine is a potent H(1)-antihistamine, which is available as a topical nasal spray and indicated for both seasonal allergic and non-allergic vasomotor rhinitis. In addition to its antihistaminic effects, it has also been shown to have a number of other potentially important attributes, including effects on cytokines, adhesion molecules and inflammatory cells. Azelastine nasal spray has been shown to benefit patients who have not responded adequately to loratadine and fexofenadine, and is significantly more efficacious than cetirizine and levocabastine in patients with seasonal allergic rhinitis. Given its unique pharmacologic properties and clinical profile, azelastine maintains an important role in the treatment of chronic rhinitis.
Similar articles
-
Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.Curr Med Res Opin. 2007 Oct;23(10):2441-52. doi: 10.1185/030079907X226302. Curr Med Res Opin. 2007. PMID: 17723160 Review.
-
Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.Ann Allergy Asthma Immunol. 1999 Jun;82(6):535-41. doi: 10.1016/s1081-1206(10)63161-4. Ann Allergy Asthma Immunol. 1999. PMID: 10400480 Clinical Trial.
-
Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.Pharmacotherapy. 2007 Jun;27(6):852-9. doi: 10.1592/phco.27.6.852. Pharmacotherapy. 2007. PMID: 17542768
-
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.Curr Med Res Opin. 2005 Apr;21(4):611-8. doi: 10.1185/030079905X41408. Curr Med Res Opin. 2005. PMID: 15899111 Clinical Trial.
-
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.Expert Opin Pharmacother. 2015 Apr;16(6):913-28. doi: 10.1517/14656566.2015.1020789. Epub 2015 Mar 7. Expert Opin Pharmacother. 2015. PMID: 25747125 Review.
Cited by
-
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients.Pharmaceutics. 2022 Sep 27;14(10):2059. doi: 10.3390/pharmaceutics14102059. Pharmaceutics. 2022. PMID: 36297492 Free PMC article.
-
Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.Curr Allergy Asthma Rep. 2013 Apr;13(2):203-8. doi: 10.1007/s11882-013-0341-4. Curr Allergy Asthma Rep. 2013. PMID: 23389557 Review.
-
Brazilian Academy of Rhinology position paper on topical intranasal therapy.Braz J Otorhinolaryngol. 2013 May-Jun;79(3):391-400. doi: 10.5935/1808-8694.20130067. Braz J Otorhinolaryngol. 2013. PMID: 23743757 Free PMC article. Review.
-
Developing Nanosuspension Loaded with Azelastine for Potential Nasal Drug Delivery: Determination of Proinflammatory Interleukin IL-4 mRNA Expression and Industrial Scale-Up Strategy.ACS Omega. 2023 Jun 21;8(26):23812-23824. doi: 10.1021/acsomega.3c02186. eCollection 2023 Jul 4. ACS Omega. 2023. PMID: 37426214 Free PMC article.
-
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.Ther Clin Risk Manag. 2008 Oct;4(5):1009-22. doi: 10.2147/tcrm.s3229. Ther Clin Risk Manag. 2008. PMID: 19209282 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources